TickerFacts.

Axim Biotechnologies, Inc. (AXIM): Total Assets

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2011-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$4.12M
As of 2023-12-31
-28.6%
3-year compound annual growth
+14.6%
5-year compound annual growth
n/m
10-year compound annual growth
$11.31M2010-12-31: $02011-12-31: $137.3K2012-12-31: $132.8K2013-12-31: $56.8K2014-12-31: $738.5K2015-12-31: $1.26M2016-12-31: $1.45M2017-12-31: $2.19M2018-12-31: $2.09M2019-12-31: $1.69M2020-12-31: $11.31M2021-12-31: $5.32M2022-12-31: $4.21M2023-12-31: $4.12M$4.12M
2010-12-31 Total Assets (USD) 2023-12-31
Period endedTotal AssetsChange YoYSource filing
2023-12-31$4.12M-2.1%2024-04-16, Balance as of period end
2022-12-31$4.21M-20.9%2024-04-16, Balance as of period end
2021-12-31$5.32M-52.9%2023-04-17, Balance as of period end
2020-12-31$11.31M+568.7%2022-04-19, Balance as of period end
2019-12-31$1.69M-19.0%2021-04-26, Balance as of period end
2018-12-31$2.09M-4.7%2020-05-20, Balance as of period end
2017-12-31$2.19M+51.3%2019-04-08, Balance as of period end
2016-12-31$1.45M+14.9%2018-03-15, Balance as of period end
2015-12-31$1.26M+70.8%2017-09-14, Balance as of period end
2014-12-31$738.5Kn/m2016-04-18, Balance as of period end
2013-12-31$56.8K-57.2%2015-04-14, Balance as of period end
2012-12-31$132.8K-3.3%2014-03-04, Balance as of period end
2011-12-31$137.3Kn/c2013-04-15, Balance as of period end
2010-12-31$0n/a2012-05-01, Balance as of period end